NIHR Biomedical Research Centre: UCLH

The Biomedical Research Centre at UCLH is a partnership between @uclh & @ucl, funded by @NIHRresearch, to develop experimental medicine.

[NIHR Biomedical Research Centre: UCLH @UCLHresearch]

MPs, experts & families affected by Friedreich's Ataxia (FA) have called on the government to enable interim access to Omaveloxolone - the first licensed treatment for the rare neurodegenerative disease & the only one shown to slow its progression.

https://t.co/J0HcKnBUZP

[NIHR Biomedical Research Centre: UCLH @UCLHresearch]

Widely used cardiovascular risk calculators could also help identify people at higher risk of certain cancers, according to new research from @ucl.

https://t.co/GOAufc2f6C

[NIHR Biomedical Research Centre: UCLH @UCLHresearch]

A new treatment for early Alzheimer’s disease has shown encouraging results with @uclh consultant, Professor Cath Mummery, reporting both slower cognitive decline and significant reductions in the tau protein in the brains of participants. @biogen

https://t.co/PsT71uPWiC

[NIHR Biomedical Research Centre: UCLH @UCLHresearch]

Today we go #Red4Research!

Staff wore red this week to mark the annual campaign, with the UCL portico building and the BT Tower lit up in red to thank everyone involved in #research.

More: https://t.co/9M5remv5Nt

@TheRDForum @uclh @ucl

[NIHR Biomedical Research Centre: UCLH @UCLHresearch]

Clinician researchers at @uclh & @ucl are leading a UK trial testing whether proton beam therapy could improve survival for people with mesothelioma, a rare aggressive lung cancer.

The HIT-MESO trial aims to increase 2-year survival from ~30% to 50%.

https://t.co/3Cc5JCulT8

[NIHR Biomedical Research Centre: UCLH @UCLHresearch]

A new modelling study from researchers @ucl and the Severn Major Trauma Network suggests that patients urgently requiring a breathing tube are more likely to survive if the tube is inserted before arriving at hospital compared to insertion afterwards.

https://t.co/8hPSabT5i5

[NIHR Biomedical Research Centre: UCLH @UCLHresearch]

Sebastian Gomez, a medical student @UCLMS shared his story with @SkyNews, saying the technology gave him a “new piece of hope.”

Read and watch more about his story ⬇️

https://t.co/7HIiLcyqdn

[NIHR Biomedical Research Centre: UCLH @UCLHresearch]

🧠 There are now seven patients participating in the GB-PRIME study involving @neuralink's brain-computer interface technology.

The technology aims to improve independence for those who are paralysed.

All patients surgeries were conducted at @uclh.

https://t.co/8LWTM8MtjJ

[NIHR Biomedical Research Centre: UCLH @UCLHresearch]

📢 The UCLH Research Open Day is back!

Be part of our interactive event, 9 July, showcasing healthcare advancements to the public.

Teams are invited to apply to:
- Demonstrate cutting-edge research
- Encourage participation in research

Apply now ⬇️
https://t.co/Z8okIEI8I3

[NIHR Biomedical Research Centre: UCLH @UCLHresearch]

Happy Birthday, UCL 🎉

We're proud to be celebrating the strong collaboration between @ucl and @uclh, centred on our @NIHRresearch BRC, that continues to accelerate the translation of research into real-world healthcare innovation.

[UCLH @uclh]

Happy Birthday @UCL! 🎂

Today, UCL begins a year of celebration to mark its bicentenary. It was on this very date 200 years ago that the title deeds of settlement for the university were signed.

Learn more about the UCL200 programme and celebrations: https://t.co/f6mmYucedm

[Sky News @SkyNews]

Man given Musk's Neuralink brain chip in UK trial says it 'feels magical' and gives new hope

Science and technology editor @t0mclark3 reports

https://t.co/0wqoIYnE9h

[UCL Translational Research Office @UCLTRO]

Register now! The @ucl Advanced Therapies Symposium returns on 22 April 2026.  This event brings together 250+ researchers, clinicians, funders & industry to explore breakthroughs from lab to market. More info: https://t.co/tAVFIA7ZwV

#UCL2026AdvTx @UCLEnterprise @UCL_Business

[NIHR Biomedical Research Centre: UCLH @UCLHresearch]

✏️ Registration for our PPIE Workshops is now open

The training aims to equip researchers with practical skills for meaningful patient and public involvement.

Open to researchers across the UK and internationally.

💻 Virtual, Feb-June
⬇️ Book now

https://t.co/BElLCrQ85a

[NIHR Biomedical Research Centre: UCLH @UCLHresearch]

Men in England with high-risk locally advanced prostate cancer will soon be offered abiraterone on the NHS, following findings co-led by @uclh oncologist Prof Gert Attard.

The trial showed treatment can halve the risk of death & slow disease progression.

https://t.co/ro1GRMFdXb

[UCL Translational Research Office @UCLTRO]

🚀 Bridging the Regulatory Gap in Medical Device Research
@UCL researchers & innovators: Join us on 6 Feb for expert insights, case studies & networking to accelerate your path to commercialisation.
📍 UCL BaseKX | 🔗 Register: https://t.co/MkiahECYwJ

[NIHR Biomedical Research Centre: UCLH @UCLHresearch]

New research from experts at @ucl and @Cambridge_Uni highlights that individuals prescribed new-generation weight loss drugs may not be getting enough nutritional guidance - increasing the risk of nutrient deficiencies and muscle loss.

https://t.co/pQyzMSK38t

[NIHR Biomedical Research Centre: UCLH @UCLHresearch]

🎉 As we step into 2026, we’re taking a moment to celebrate a brilliant year for BRC-supported research at UCLH and UCL.

From breakthrough discoveries to real-world impact, our exceptional research teams and delivery staff have achieved so much together.

[NIHR Biomedical Research Centre: UCLH @UCLHresearch]

From everyone at the @NIHRresearch UCLH Biomedical Research Centre, we wish our colleagues, researchers, partners, patient/public contributors and friends a Merry Christmas and all the best over the festive period 🎄

[NIHR Biomedical Research Centre: UCLH @UCLHresearch]

💉 Help find a vaccine against Paratyphoid A Fever

We’re looking for volunteers to take part in the BiVISTA study @uclh.

We’re recruiting:
👉 Healthy adults, aged 18-55
👉 Duration ~7 months
👉 Up to 31 visits at UCLH
👉 Reimbursement up to £4,410

https://t.co/78EDeThBIO

[NIHR Biomedical Research Centre: UCLH @UCLHresearch]

A new daily pill, baxdrostat, has shown sustained 24 hour blood pressure control for people whose condition is particularly difficult to manage.

The global study was led by Professor Bryan Williams, @ucl.

@NIHRresearch

https://t.co/PJghTM1gYY